| [1] |
Habib R, Kleinknecht C, Gubler MC, et al. Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases [J]. Clin Nephrol, 1973, 1(4): 194-214.
|
| [2] |
Strife CF, McEnery PT, McAdams AJ, et al. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane [J]. Clin Nephrol, 1977, 7(2): 65-72.
|
| [3] |
Cameron JS, Turner DR, Heaton J, et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types i and ii in children and adults and long-term prognosis [J]. Am J Med, 1983, 74(2): 175-192.
|
| [4] |
D′Amico G, Ferrario F. Mesangiocapillary glomerulonephritis [J]. J Am Soc Nephrol, 1992, 2(10 Suppl): S159-S166.
|
| [5] |
Ferri C, Greco F, Longombardo G, et al. Association between hepatitis c virus and mixed cryoglobulinemia [J]. Clin Exp Rheum, 1991, 9(6): 621-624.
|
| [6] |
Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis [J]. Arthritis Rheum, 1990, 33(8): 1129-1134.
|
| [7] |
Hong Y, Zhou W, Li K, et al. Triptolide is a potent suppressant of c3, cd40 and b7h expression in activated human proximal tubular epithelial cells [J]. Kidney Int, 2002, 62(4): 1291-1300.
|
| [8] |
Tarshish P, Bernstein J, Tobin JN, et al. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the international study of kidney disease in children [J]. Pediatr Nephrol, 1992, 6(2): 123-130.
|
| [9] |
Jones G, Juszczak M, Kingdon E, et al. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids [J]. Nephrol Dial Transplant, 2004, 19(12): 3160-3164.
|
| [10] |
Belgiojoso GB, Tarantino A, Bazzi C, et al. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (mpgn) [J]. Clin Nephrol, 1976, 6(1): 303-310.
|
| [11] |
Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu′s arteritis [J]. Clinical rheumatology, 2013, 32(5): 541-546.
|
| [12] |
Kuroda T, Ueno M, Sato H, et al. A case of Takayasu arteritis complicated with glomerulonephropathy mimicking membranoproliferative glomerulonephritis: A case report and review of the literature [J]. Rheum Int, 2006, 27(1): 103-107.
|
| [13] |
Cavatorta F, Campisi S, Trabassi E, et al. IgA nephropathy associated with Takayasu′s arteritis: report of a case and review of the literature [J]. Am J Nephrol, 1995, 15(2): 165-167.
|
| [14] |
Tiryaki O, Buyukhatipoglu H, Onat AM, et al. Takayasu arteritis: association with focal segmental glomerulosclerosis [J]. Clin Rheum, 2007, 26(4): 609-611.
|
| [15] |
Hellmann DB, Hardy K, Lindenfeld S, et al. Takayasu′s arteritis associated with crescentic glomerulonephritis [J]. Arthritis Rheum, 1987, 30(4): 451-454.
|
| [16] |
Pablo PD, Torres RG, Uribe N, et al. Kidney involvement in Takayasu arteritis [J]. Clin Exp Rheumatol, 2007, 25(1 Suppl 44): S10-S14.
|
| [17] |
Koda R, Yoshino A, Imanishi Y, et al.: A case of membranous glomerulonephropathy associated with Takayasu′s arteritis [J]. Case Rep Nephrol Urol, 2014, 4(1): 60-69.
|
| [18] |
Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop[J]. Arthritis Rheum, 1999, 42(7): 1309-1311.
|
| [19] |
Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome [J]. Lancet, 2010, 376(9751): 1498-1509.
|
| [20] |
Boyer NL, Niven A, Edelman J. Tacrolimus-associated thrombotic microangiopathy in a lung transplant recipient [J]. BMJ Case Rep, 2013, 2013: bcr2012007351.
|
| [21] |
Odek C, Kendirli T, Yaman A, et al. Cyclosporine-associated thrombotic microangiopathy and thrombocytopenia-associated multiple organ failure: a case successfully treated with therapeutic plasma exchange [J]. J Pediatr Hematol Oncol, 2014, 36(2): e88-e90.
|
| [22] |
Ruggenenti P, Ruggiero B, Cravedi P, et al. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome [J]. J Am Soc Nephrol, 2014, 25(4): 850-863.
|
| [23] |
Kronbichler A, and Bruchfeld A. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis [J]. Nephron Clin Pract, 2014, 128(3-4): 277-282.
|
| [24] |
Kronbichler A, Kerschbaum J, Fernandez-Fresnedo G, et al. Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review [J]. Am J Nephrol, 2014, 39(4): 322-330.
|
| [25] |
Kamei K, Okada M, Miyazono A, et al. Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab [J]. Nihon Jinzo Gakkai Shi, 2013, 55(5): 947-955.
|
| [26] |
Guitard J, A. Hebral L, Fakhouri F, et al. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance [J]. Nephrol Dial Transplant, 2014, 29(11): 2084-2091.
|